iRobot 2013 Annual Report Download - page 42

Download and view the complete annual report

Please find page 42 of the 2013 iRobot annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 128

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128

36
DIRECTOR COMPENSATION TABLE — 2013
Name
Fees Earned or
Paid in Cash
($) Stock Awards
($)(3) Total ($)
Ronald Chwang, Ph.D. 42,500 109,973 152,473
Gail Deegan 45,000 109,973 154,973
Deborah G. Ellinger 42,500 109,973 152,473
Jacques S. Gansler, Ph.D. 40,000 109,973 149,973
Andrea Geisser 55,000 109,973 164,973
Paul J. Kern, Gen. U.S. Army (ret.) 45,000 109,973 154,973
George C. McNamee 60,750 109,973 170,723
Peter T. Meekin (2) 10,000 — 10,000
Paul L. Sagan (1) 45,000 109,973 154,973
(1) Mr. Sagan deferred all of his 2013 cash compensation pursuant to our Non-employee Directors’ Deferred Compensation
Program under which he received stock units in lieu of cash.
(2) Mr. Meekin did not stand for re-election at the 2013 annual meeting of stockholders.
(3) Represents the grant date fair value of restricted stock units awarded in the fiscal year ended December 28, 2013 in accordance
with FASB ASC Topic 718. The grant date fair value is the fair market value of our common stock on the date of grant
multiplied by the number of shares of common stock underlying such restricted stock unit award.
The non-employee members of our board of directors who held such position on December 28, 2013 held the following
aggregate number of unexercised options and unvested restricted stock units as of such date:
Name
Number of
Securities
Underlying
Unexercised
Options
Number of
Unvested
Restricted
Stock
Units
Ronald Chwang, Ph.D. 40,000 3,172
Gail Deegan — 6,230
Deborah G. Ellinger — 8,699
Jacques S. Gansler, Ph.D. — 3,172
Andrea Geisser 50,000 3,172
Paul J. Kern, Gen. U.S. Army (ret.) 70,000 3,172
George C. McNamee 80,000 3,172
Paul L. Sagan 25,000 3,172
Transactions with Related Persons
Other than compensation agreements and other arrangements which are described in “Compensation Discussion & Analysis,” in
2013, there was no transaction or series of similar transactions to which we were or will be a party in which the amount involved
exceeded or will exceed $120,000 and in which any director, executive officer, holder of five percent or more of any class of our
capital stock or any member of their immediate family had or will have a direct or indirect material interest.
Our board of directors has adopted a written related party transaction approval policy, which sets forth our policies and
procedures for the review, approval or ratification of any transaction required to be reported in our filings with the Securities and
Exchange Commission. Our policy with regard to related party transactions is that all related party transactions are to be reviewed by
our general counsel, who will determine whether the contemplated transaction or arrangement requires the approval of the board of
directors, the nominating and corporate governance committee, both or neither.